Popular generic drugs in the USA had substantial price increases between 2006 and 2013, with some prices going up as much as 1,000%, according to a new Rx Price Watch Report from AARP Public Policy Institute (PPI).
The report, Trends in Retail Prices of Generic Prescription Drugs Widely Used by Older Americans: 2006 to 2013, looked at the 2013 retail prices for 280 of the generic drugs most widely used by older Americans. The report shows that the majority (73%) of widely used generic drug products included in the study experienced price decreases, some of them substantial. Overall, retail prices for generic prescription drugs widely used by older Americans fell an average of 4% in 2013, the smallest average annual decline since at least 2006, a sign that the era of falling prices for generic drugs could be coming to an end.
Debra Whitman, AARP executive vice president for policy, said: “Declining generic drug prices have helped many Americans' pocketbooks, particularly older adults on fixed incomes. Unfortunately, recent trends indicate that we may not be able to rely on these savings forever.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze